From the Departments of Plastic Surgery and Burns Treatment and Neurosurgery, Copenhagen University Hospital, Rigshospitalet; and the Institute of Plastic Surgery, University of Padua, and C.S.M. Institute for Plastic Regenerative Surgery.
Plast Reconstr Surg. 2020 Mar;145(3):530e-537e. doi: 10.1097/PRS.0000000000006569.
Breast augmentation with fat grafting is used as an alternative to breast implants. However, a systematic evaluation of the complication rates after fat grafting using only studies with consecutive patients has not previously been performed. In this study, the authors compiled studies reporting complication rates and radiologic changes in consecutive patients undergoing cosmetic breast augmentation with fat grafting.
Studies reporting on consecutive patients undergoing breast augmentation with fat grafting were included. Complication rates, radiologic changes, Breast Imaging Reporting and Data System assessments, and the number of patients undergoing revision surgery were extracted. Mean complication rates and radiologic changes were calculated with meta-analytical methods.
Twenty-two studies with 2073 patients were included. The rates of major complications were low (hematoma, 0.5 percent; infection, 0.6 percent; and seroma, 0.1 percent). None of these patients needed revision surgery. The most frequent minor complication was palpable cysts in 2.0 percent of the patients; 67 percent of these were treated with aspiration. The radiologic changes in the patients after fat grafting were as follows: oil cysts, 6.5 percent; calcifications, 4.5 percent; and fat necrosis, 1.2 percent. The risk of being referred for additional radiologic imaging (e.g., to exclude malignant changes) was 16.4 percent, and the risk of being referred for biopsy was 3.2 percent.
The complication rates after breast augmentation with fat grafting are low and support fat grafting as an alternative to breast augmentation with implants. The rates of radiologic changes are high after fat grafting, but the changes do not seem to have any therapeutic consequences for the patients.
脂肪移植隆乳术可作为乳房植入物的替代方法。然而,之前尚未进行仅使用连续患者研究对脂肪移植后并发症发生率进行系统评估。在这项研究中,作者汇编了报告接受脂肪移植隆乳术的连续患者的并发症发生率和影像学变化的研究。
纳入报告接受脂肪移植隆乳术的连续患者的研究。提取并发症发生率、影像学变化、乳腺影像报告和数据系统(Breast Imaging Reporting and Data System,BI-RADS)评估以及接受修正手术的患者数量。采用荟萃分析方法计算平均并发症发生率和影像学变化。
共纳入 22 项研究,涉及 2073 例患者。主要并发症发生率较低(血肿 0.5%,感染 0.6%,血清肿 0.1%),这些患者均无需进行修正手术。最常见的轻微并发症是患者中有 2.0%出现可触及的囊肿,其中 67%的囊肿通过抽吸进行了治疗。脂肪移植后患者的影像学变化如下:油囊肿 6.5%,钙化 4.5%,脂肪坏死 1.2%。需要进一步影像学检查(例如,排除恶性变化)的风险为 16.4%,需要进行活检的风险为 3.2%。
脂肪移植隆乳术后的并发症发生率较低,支持将脂肪移植作为乳房植入物的替代方法。脂肪移植后影像学变化的发生率较高,但这些变化似乎对患者没有任何治疗影响。